mProX™ Human FRK Stable Cell Line
- Product Category:
- Membrane Protein Stable Cell Lines
- Subcategory:
- Kinase Cell Lines
To download a Certificate of Analysis, please enter a lot number in the search box below. Note: Certificate of Analysis not available for kit components.
Lot Number
Made to Order Inquiry
InquiryProduct Information
Product Properties
Protocols
Please visit our protocols page.
Customer Reviews
Anthony
Verified Customer
Richard
Verified Customer
Any questions about our products? Please visit our frequently asked questions page.
Published Data
Fig.1 Effect of FRK expression on cell proliferation and anchorage-independent growth.
MDA-MB-231 cells were retrovirally infected with vectors encoding either FRK Y497F (FRK-YF) or wild-type FRK (FRK-WT), from which monoclonal populations were generated and named accordingly. Through quantitative RT-PCR analysis, the expression of FRK mRNA in the designated stable cell lines was ascertained.
Ref: Ogunbolude, Yetunde, et al. "FRK inhibits breast cancer cell migration and invasion by suppressing epithelial-mesenchymal transition." Oncotarget 8.68 (2017): 113034.
Pubmed: 29348886
DOI: 10.18632/oncotarget.22958
Research Highlights
Fyn-related kinase (FRK), a non-receptor tyrosine kinase, belongs to the BRK family of kinases (BFKs) and shares a distant relationship with the Src family of kinases (SFKs).
Goel, Raghuveera Kumar, and Kiven Erique Lukong. "Understanding the cellular roles of Fyn-related kinase (FRK): implications in cancer biology." Cancer and Metastasis Reviews 35 (2016): 179-199.
Pubmed:
27067725
DOI:
10.1007/s10555-016-9623-3
By stimulating metabolic reprogramming, which ultimately encourages EMT and metastasis, FRK enhances the stemness of H1299 cells and hence plays an oncogenic function in lung cancer cells.
Zhang, Li, et al. "FRK plays an oncogenic role in non-small cell lung cancer by enhancing the stemness phenotype via induction of metabolic reprogramming." International Journal of Cancer 146.1 (2020): 208-222.
Pubmed:
31251822
DOI:
10.1002/ijc.32530